Sight Sciences share price logo

Sight Sciences

NASDAQ: SGHT

Small Cap

$8.55

+0.14

(+1.66%)

as on

Sight Sciences Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $8.32
    $8.54
    downward going graph

    2.69%

    Downside

    -0.12%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.19
    $9.24
    downward going graph

    62.69%

    Downside

    8.03%

    Upside

    downward going graph

Sight Sciences share price movements today

Previous Close
$8.41
Open
$8.35
Volume
198.9K
Market Cap
$461.1M
Day's Low - High
$8.32 - $8.54
52 Week Low - High
$3.19 - $9.24

Sight Sciences Historical Returns

1 Month Return
+ 58.68 %
3 Month Return
+ 66.21 %
1 Year Return
+ 108.17 %
3 Year Return
+ 32.86 %
5 Year Return
-75.8 %

Sight Sciences Stock Fundamentals & Key Indicators

Check Sight Sciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$461.1M

EPS (TTM)

-0.4926

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.3M

Revenue (TTM)

83.4M

Profit Margin

-35.69%

Return On Equity TTM

-48.42%

Sight Sciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sight Sciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$461.1M-75.8%NA-35.69%NA
BUY$125.7B17.81%34.2314.43%105.3%
BUY$52.3B-22.72%53.277.98%NA
BUY$116.7B-32.76%24.1565.02%3.15%
BUY$201.9B-10.43%37.5311.65%213.54999999999998%

Stock Returns calculator for Sight Sciences Stock including INR - Dollar returns

The Sight Sciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Sight Sciences investment value today

Current value as on today

₹2,28,929

Returns

₹1,28,929

(+128.93%)

Returns from Sight Sciences Stock

₹1,11,634 (+111.63%)

Dollar Impact

₹17,296 (+17.3%)

Analyst Recommendation on Sight Sciences Stock

Based on 7 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 7 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Sight Sciences. Average target price of $9

Sight Sciences Share Price Target

Get share price movements and forecasts by analysts on Sight Sciences.

What analysts predicted

5%UPSIDE

Target Price

$9

Current Price

$8.55

Analyzed by

7 Analysts

Target

$9.00

Sight Sciences target price $9, a slight upside of 5% compared to current price of $8.55. According to 7 analysts rating.

Indian Investors' Interest in Sight Sciences Stock

Search interest for Sight Sciences Stock has increased by 180% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:180% versus previous 30 day period

Sight Sciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
19
21
20
19
17
19
19
20
19
23
Gross Profit
16
18
16
16
15
16
17
17
16
21
Operating Income
-14
-12
-11
-11
-13
-11
-7
-3
-12
-3
EBITDA
-14
-11
-9
-10
-12
-10
-6
-2
-11
-4
Interest Expense
1
1
1
1
1
1
1
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-12
-10
-11
-14
-11
-8
-4
-12
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-12
-11
-11
-14
-11
-8
-4
-12
-4
Net Profit Margin
-84.43%
-57.69%
-54.90%
-62.11%
-80.84%
-61.04%
-41.04%
-20.42%
-65.90%
-19.01%

Sight Sciences Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
23
27
48
71
81
79
77
Gross Profit
5
16
18
40
58
69
68
66
Operating Income
-14
-24
-32
-51
-83
-57
-50
-37
EBITDA
-14
-23
-31
-57
-80
-49
-45
-32
Interest Expense
-
1
2
4
4
5
4
5
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-14
-25
-34
-62
-86
-55
-51
-38
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-14
-25
-34
-62
-86
-55
-51
-38
Net Profit Margin
-189.77%
-110.80%
-125.52%
-128.61%
-120.90%
-68.53%
-64.49%
-49.67%

Sight Sciences Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-11
-11
-14
-11
-8
-4
-12
-4
Operating Cash Flow
-9
0
-3
-11
-7
-8
-1
-7
-5
Investing Cash Flow
0
0
0
-
0
0
0
0
0
Financing Cash Flow
0
0
5
0
0
0
1
0
0
Change in Cash
-9
0
1
-11
-7
-8
0
-7
-5

Sight Sciences Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-25
-34
-62
-86
-55
-51
-38
Operating Cash Flow
-24
-32
-52
-75
-47
-22
-29
Investing Cash Flow
0
0
0
0
0
0
0
Financing Cash Flow
42
73
252
1
1
4
1
Change in Cash
16
40
199
-75
-46
-17
-28

Mutual Funds that own Sight Sciences Stock

Check out the Mutual Funds with significant holdings in Sight Sciences.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.572716%
1417258
Fidelity Salem Street Trust
0.819056%
451202
Fidelity Concord Street Trust
0.624027%
343764
VANGUARD SCOTTSDALE FUNDS
0.451292%
248608
DFA INVESTMENT DIMENSIONS GROUP INC
0.221124%
121813

Global Institutional Holdings in Sight Sciences

Funds
Holdings
Vanguard
3.28%
iShares
3.26%
Dimensional
0.35%
Schwab
0.33%
SPDR
0.2%

Sight Sciences News & Key Events

  • img

    Today's Timeline - 09 September

    Tue, 09:09 PM

    -

    UnitedHealthcare expands coverage for glaucoma surgeries, effective October 1, 2025, enhancing Sight Sciences' market position.

Insights on Sight Sciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SGHT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 19.69M → 23.38M (in $), with an average increase of 15.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -12.97M → -4.44M (in $), with an average increase of 192.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SGHT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SGHT stock has moved up by 60.1%

About Sight Sciences

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
OrganisationSight Sciences
Headquarters4040 Campbell Avenue, Menlo Park, CA, United States, 94025
IndustryMedical Devices
CEOMr. Paul Badawi
E-voting on sharesClick here to vote

Key Management of Sight Sciences

Name

Title

Mr. Paul Badawi

Co-Founder, President, CEO & Director

Ms. Alison Perry Bauerlein

Chief Operating Officer

Dr. David Badawi M.D.

Co-Founder, CTO & Director

Mr. James Rodberg

CFO & Treasurer

Mr. Steve R. Tamayo Jr.

VP and Chief Ethics & Compliance Officer

FAQs

What is Sight Sciences share price today?

Sight Sciences share price today is $8.55 as on at the close of the market. Sight Sciences share today touched a day high of $8.54 and a low of $8.32.

What is the 52 week high and 52 week low for Sight Sciences share?

Sight Sciences share touched a 52 week high of $9.24 on and a 52 week low of $3.19 on . Sight Sciences stock price today i.e. is closed at $8.55,which is 7.43% down from its 52 week high and 168.03% up from its 52 week low.

What is Sight Sciences's market capitalisation today?

Sight Sciences market capitalisation is $0.00T as on .

How to invest in Sight Sciences Stock (SGHT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sight Sciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sight Sciences Shares that will get you 0.1754 shares as per Sight Sciences share price of $8.55 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Sight Sciences Stock (SGHT) from India?

Indian investors can start investing in Sight Sciences (SGHT) shares with as little as ₹95.38 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Sight Sciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Sight Sciences share’s latest price of $8.55 as on August 29, 2026 at 8:46 am IST, you will get 1.1696 shares of Sight Sciences. Learn more about fractional shares .

What are the returns that Sight Sciences has given to Indian investors in the last 5 years?

Sight Sciences stock has given -75.8% share price returns and 30.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?